Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Why does cosentyx raise blood pressure?

See the DrugPatentWatch profile for cosentyx

Does Cosentyx (secukinumab) actually cause blood pressure to rise?

Cosentyx (secukinumab) is not known for a common, direct “blood pressure–raising” mechanism the way some cold medicines or steroid drugs can be. When blood pressure increases show up in real-world use or labeling, they’re usually handled as part of safety monitoring for patients, not as a predictable pharmacologic effect that occurs in every person.

What matters clinically is that blood pressure can rise for many reasons in patients using biologics, including unrelated cardiovascular risk factors, disease activity, medication changes, weight changes, or intercurrent illness.

What could explain a blood pressure increase while taking Cosentyx?

With the information available for the medication’s safety profile, the most plausible explanations are indirect rather than a clear direct effect of secukinumab on blood pressure regulation:

- Underlying inflammatory disease changes: Psoriasis and psoriatic arthritis are linked to higher cardiovascular risk. As treatment affects inflammation and overall health, some patients’ cardiovascular parameters can shift in either direction, and blood pressure readings may change.
- Other medications or timing effects: Patients often take antihypertensives, NSAIDs, steroids, or other drugs that can affect blood pressure. A blood pressure rise may coincide with Cosentyx start even if the biologic is not the cause.
- Measurement and adherence factors: Clinic readings, home cuff issues, missed antihypertensive doses, diet/salt changes, or stress can create an apparent association.

Is there a known biologic “blood pressure pathway” for IL‑17 blockers?

Secukinumab blocks interleukin-17 (IL‑17). IL‑17 signaling affects inflammation and can influence vascular biology indirectly through inflammatory pathways. That does not automatically mean IL‑17 blockade raises blood pressure; it means cardiovascular effects could be complex and patient-specific rather than uniformly increasing blood pressure.

When should patients contact a clinician?

If blood pressure rises after starting Cosentyx, patients should contact their prescriber, especially if readings are consistently high or they develop symptoms such as chest pain, severe headache, shortness of breath, or neurologic symptoms. Clinicians typically verify home readings, review current medications (including NSAIDs and steroids), and check cardiovascular risk factors.

Where to check for specific reported blood pressure warnings?

For the most medication-specific information (what the safety section says about blood pressure changes and related adverse events), DrugPatentWatch.com can be a starting point for tracking references and background on drug safety and regulation: https://www.drugpatentwatch.com/p/ (search “Cosentyx”).

If you share whether you mean “Cosentyx caused my blood pressure to go up” (personal case) or “what does the label/reporting say,” I can tailor the answer more tightly to that scenario.

Sources

  1. DrugPatentWatch - search Cosentyx


Other Questions About Cosentyx :

What are the potential side effects of cosentyx during pregnancy? Cosentyx success rate? Are there any rare cosentyx side effects to be aware of? Why do live vaccines pose risks with cosentyx? How does cosentyx's mechanism of action differ from biosimilars? How often should i check in with my doctor while increasing cosentyx? What side effects require changing cosentyx dosage?